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Abstract 
Background: Limonoids are highly oxygenated compounds with a prototypical structure. Their occurrence in the 
plant kingdom is mainly confined to plant families of Meliaceae and Rutaceae. Owing to their wide range of phar-
macological and therapeutic properties, this study was aimed at investigating the potential nitric oxide (NO) and 
acetylcholinesterase (AChE) inhibitory activity and the cytotoxicity of three limonoids: trichilia lactone D5 (1), rohituka 
3 (2) and dregeanin DM4 (3), isolated from Trichilia welwitschii C.DC.
Results: Results indicated that the three limonoids had low cytotoxicity towards Vero cells with LC50 values ranging 
from 89.17 to 75.82 μg/mL. Compounds (2) and (3) had lower cytotoxicity compared to puromycin and doxorubicin 
used as reference cytotoxic compounds. Compound (1) (LC50 of 23.55 μg/mL) had good antiproliferative activity 
against RAW 264.7 cancer cells. At the lowest concentration tested (0.5 µg/mL), compound (2) and (3) released the 
lowest amount of nitric oxide (2.97 and 2.93 µM, respectively). The three limonoids had anti-AChE activity with IC50 
values ranged of 19.13 μg/mL for (1), 34.15 μg/mL for (2) and 45.66 μg/mL for (3), compared to galantamine (IC50 of 
8.22 μg/mL) used as positive control.
Conclusion: The limonoid compounds studied in this work inhibited nitric oxide production in LPS-stimulated 
macrophages and had anti-AChE activity. Trichilia lactone D5 had potential antiproliferative activity against RAW 264.7 
cancer cells. The limonoids had low cytotoxicity towards Vero cells lines. This study provided further examples of the 
importance of limonoids compounds as potential AChE inhibitors and anti-inflammatory agents targeting the inhibi-
tion of NO production.
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Background
Nitric oxide (NO) is an important pro-inflammatory 
mediator involved in a wide variety of physiological and 
pathophysiological events; however overproduction of 
NO by inducible nitric oxide synthase (iNOS) results 
in severe inflammation [1]. An association between the 
development of cancer and inflammation has long-been 
documented [2]. Moreover, inflammation accelerates 
the appearance of some neurodegenerative disorders, 
such as Parkinson and Alzheimer’s diseases [3]. These 
insights are fostering new anti-inflammatory therapeu-
tic approaches to cancer and neurodegenerative diseases 
development. There is no doubt that natural prod-
ucts remain important sources of new pharmaceutical 
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compounds. Therefore, natural products research contin-
ues to explore a variety of compounds which may be used 
for the development of new drugs.
Limonoids are highly oxygenated compound with 
a prototypical structure, either containing or derived 
from a precursor with a 4,4,8-trimethyl-17-furanylster-
oid skeleton. The prototypical structure consists of four 
six-membered rings and a furan ring. It is an important 
group of metabolically altered triterpenes, which are 
limited in their distribution. Their occurrence in the 
plant kingdom is mainly confined to plant families of 
Meliaceae and Rutaceae, and occurs less frequently in 
Cneoraceae and Harrisonia sp. of Simaroubaceae [4]. 
Limonoids isolated from the plant family Meliaceae are 
more complex with very high degree of oxidation and 
structural rearrangements [5]. In recent years a large 
number of pharmacological studies have been carried 
out to indicate their beneficial effects. Medicinal prop-
erties of limonoids reported include antibacterial, anti-
fungal, antimalarial, anticancer and antiviral activities 
[6, 7]. In the last years, more than 100 limonoids have 
been isolated and characterized [8]. In our previous 
study, we reported the isolation and characterization of 
three limonoids compounds (dregeanin DM4, rohituka 
3 and trichilia lactone D5) from Trichilia welwitschii 
C.DC. [9].
Trichilia welwitschii is a West African member of the 
Meliaceae growing as a large tree in the Terra Firma For-
ests of Nigeria, Cameroon, Angola and Gabon [10]. Spe-
cies from the Meliaceae family and especially Trichilia 
genus have been well-documented for their ability to 
metabolize structurally diverse and biologically signifi-
cant triterpenoids and limonoids [11]. No previous phar-
macological study has been reported on compounds 
isolated from T. welwitschii. In our continue search of 
bioactive compounds from plants and owing to the wide 
range of pharmacological and therapeutic properties of 
limonoids, this study was carried out to investigate the 
potential antiproliferative, nitric oxide and acetylcho-




Our goal was to determine whether the limonoid com-
pounds exerted an inhibitory effect on cancer cell prolifer-
ation and their safety toward normal Vero cells. Therefore 
cytotoxic effect was evaluated against THP-1 and RAW 
264.7 cancer cell lines and Vero cells as control. Doxo-
rubicin and puromycin were used as standard antican-
cer drug. Puromycin is an aminonucleoside antibiotic, 
derived from the Streptomyces alboniger bacterium and 
used in cell biology as selective agent in cell culture sys-
tems for its toxicity to prokaryotic and eukaryotic cells 
[12]. Doxorubicin is commonly used to treat some leuke-
mias and Hodgkin’s lymphoma, as well as cancers of the 
bladder, breast, stomach, lung, ovaries, thyroid, soft tissue 
sarcoma, multiple myeloma, and others [13]. The respec-
tive LC50 values and selectivity index (SI) are presented 
in Table 1. All the compounds had some level of toxicity 
which could be considered as weak or moderate cytotoxic-
ity compared to puromycin and doxorubicin (LC50 values 
of 1.15–5.32 and 1.06–9.35  μg/mL respectively) used as 
reference cytotoxic compounds. The selectivity index (SI) 
values varied from 0.83 to 2.99 for limonoid compounds. 
The compounds were not toxic to Vero cells with LC50 
values ranging from 89.17 to 75.82 μg/mL. The LC50 val-
ues varied between 81.20 and 84.53 μg/mL on THP-1. No 
significant antiproliferative activity was noted against the 
cancer cells with the exception of compound (1) with LC50 
value of 23.55 μg/mL on RAW 264.7 cells. These results 
suggested that compounds 2 and 3 are not useful as anti-
proliferative therapeutic agent, due to their high IC50 con-
centration against THP-1 and RAW 264.7 cells. However, 
the potential antiproliferative effects of trichilia lactone D5 
(1) against RAW 264.7 cancer cells is in line with previous 
Table 1 Cytotoxicity (LC50 in  µg/mL) and  the selectivity index (SI) of  three limonoids isolated from  Trichilia welwitschii 
and reference compounds (doxorubicin and puromycin) against cancer cell lines
Values with different letters are significantly different at p < 0.05
nd not determined
Compounds Vero THP-1 RAW 264.7
LC50 SI LC50 SI
1 89.17 ± 5.00a 81.20 ± 6.38a 0.87 23.55 ± 5.77a 2.99
2 85.22 ± 6.31a 81.20 ± 4.04a 0.87 65.68 ± 3.64b 1.07
3 75.82 ± 1.85b 84.53 ± 5.81a 0.83 61.86 ± 4.14b 1.14
Doxorubicin 9.35 ± 0.66c nd nd 1.06 ± 0.65c 66.42
Puromycin 5.32 ± 0.90d 0.4 ± 0.02b 176.03 1.15 ± 0.17c 61.23
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reports on the antiproliferative activity of limonoids com-
pounds [14–16].
NO inhibitory activity
Macrophages produce inflammatory mediators includ-
ing NO in response to bacterial LPS; NO plays a pivotal 
role in many body functions; however, its overproduction 
can lead to cytotoxicity and inflammation [17]. There-
fore, NO inhibitors are essential for preventing inflam-
matory diseases. Nitric oxide plays an important role 
in the inflammatory process, and an inhibitor of NO 
production and may be considered as a potential anti-
inflammatory agent. Therefore, NO inhibitors are essen-
tial for preventing inflammatory diseases. Quercetin has 
been reported to significantly suppress NO production 
in LPS-stimulated RAW 264.7 murine macrophage cell 
line [18]. In this study, RAW 264.7 macrophages were 
treated with LPS and various concentrations of limonoid 
compounds and quercetin as control, then NO produc-
tion and cell viability were measured. The limonoid com-
pounds had a concentration dependent inhibition on NO 
production induced by lipopolysaccharide (LPS) in mac-
rophages (Fig.  1a). At the lowest concentration (0.5  µg/
mL), compound (2) and (3) released the lowest amount 
nitric oxide (2.97 and 2.93  µM, respectively). The cyto-
toxicity of compounds against RAW 264.7 macrophages 
was also tested by MTT assay (Fig.  1b). Compound (1) 
had slight toxic effect; while the two other compounds 
did not had significant cytotoxicity at the concentra-
tion leading to effective inhibition of NO production. 
For the two other limonoids compounds, 2-hydroxyxy-
lorumphiin F and xylorumphiin I have been described 
a moderate inhibitory activity against nitric oxide pro-
duction from LPS-activated macrophages with IC50 val-
ues of 24.5 and 31.3 μM, respectively [19]. Additionally, 
for six limonoids including trichilinin B (1), 4, ohchinin 
(7), 23-hydroxyohchininolide (8), 21-hydroxyisoohchini-
nolide (9), 10, and methyl indole 3-carboxylate (12), have 
been described and inhibited production of NO with IC50 
values in the range of 4.6–87.3 μM and with no toxicity 
to the cells [14]. Our results provided further examples of 
the importance of limonoid compounds as potential anti-
inflammatory agents targeting NO inhibition.
Acetylcholinesterase inhibition
Recognized factors in Alzheimer’s disease include free 
radicals, inflammation of the brain tissue and acetyl-
choline deficiency. Therefore, acetylcholine breakdown 
in the brain can be prevented by the inhibition of acetyl 
cholinesterase activity, leading to an increase in acetyl-
choline concentration. In the present study, limonoid 
compounds were investigated for their ability to inhibit 
the activity of AChE comparatively to galantamine. 
Results are presented in Table 2. Galantamine is a revers-
ible cholinesterase inhibitor used for the treatment of 
mild to moderate Alzheimer’s disease and various other 
memory impairments [20]. Compare to galantamine 
(IC50 of 8.22  μg/mL) used as standard AChE inhibitor; 
the three limonoids isolated from Trichilia welwitschii 
had weak to moderate inhibitory activities. At 50  µg/
mL, the inhibitory potential of limonoids 1, 2 and 3 was 
94.33, 82.67 and 87 % respectively. At the lowest concen-
tration (6.25 µg/mL), the AChE inhibitory activity of the 
three compounds dropped to 28.00, 14.00 and 30.33 % for 
limonoids 1, 2 and 3 respectively. Concentration depend-
ent inhibition was also observed and the IC50 values 
ranged from 19.13 μg/mL for compound (1) to 34.15 μg/
mL for compound (2) and 45.69  μg/mL for compound 
(3). However, all the samples had lower inhibitory activi-
ties compare with that of galantamine (IC50 8.22 μg/mL). 
Not much work has been done on the AChE activity of 
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Fig. 1 Inhibitory activity of three limonoids isolated from Trichilia 
welwitschii on nitrix oxide production. The RAW 264.7 macrophages 
cells were seeded in 96 well-microtitre plates and were activated by 
incubation in medium containing 1 µg/mL LPS alone (control) or 
lipopolysaccharide with different concentrations of the samples dis-
solved in DMSO. Nitric oxide released from macrophages was deter-
mined by measuring the nitrite concentration in culture supernatant 
using the Griess reagent. The concentrations of nitrite were derived 
from regression analysis using serial dilutions of sodium nitrite as a 
standard. Percentage inhibition was calculated based on the ability 
of compounds to inhibit nitric oxide formation by cells compared 
with the control (cells in media without compounds), which was 
considered as 0 % inhibition. Data represent the mean ± SE of three 
independent experiments ∗p < 0.05, ∗p < 0.01 and ∗∗∗p < 0.001 are 
significantly different from the reference compound quercetin
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new AChE inhibitors from natural source, but not much 
work has focused on limonoid compounds. Our com-
pounds had a much higher anti- AChE activity than the 
limonoids from Kigelia africana (Bignoniaceae) with IC50 
values in the ranges 137.5–225.2 μM [22].
Conclusion
The limonoid compounds studied in this work inhibited 
nitric oxide production in LPS-stimulated macrophages 
and presented AChE inhibitory activity. They had low 
cytotoxicity against Vero cells lines. The potential anti-
proliferative effect of compound against RAW 264.7 
cancer cells was also demonstrated. This study provided 
further examples of the importance of limonoid com-
pounds as potential AChE inhibitors and anti-inflamma-
tory agents targeting the inhibition of NO production.
Methods
Chemicals
Sodium dodecyl sulphate, bovine serum albumin (BSA), 
sodium chloride (NaCl), MgCl2·6H2O, acetylthiocholine 
iodide (ATCI), galantamine, 5,5-dithiobis-2-nitroben-
zoic acid (DTNB), acetylcholinesterase (AChE) enzyme 
from electric eels (type VI-S lyophilized powder), sodium 
nitrite, ferrous sulfate, indomethacin and 15-lipoxyge-
nase from Glycine max purchased from Sigma (Ger-
many) and Tris(hydroxymethyl)aminomethane from 
Sigma, (Switzerland). Foetal calf serum (FCS), penicillin/
streptomycin/fungizone (PSF) and Dulbecco’s modified 
Eagle’s medium (DMEM) were obtained from Highveld 
Biological Products (South Africa). Phosphate buffered 
saline (PBS) and trypsin were purchased from Whitehead 
Scientific (South Africa). Quercetin, 3-(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) were 
purchased from Sigma-Aldrich St. Louis, MO, USA.
Limonoids compounds
The three limonoids compounds (dregeanin DM4, 
rohituka 3 and trichilia lactone D5) studied in this work 
were isolated from seeds of Trichilia welwitschii. We 
previously described the isolation procedure and the 
structure elucidation of the compounds [9]. Chemical 
structures are shown in Fig. 2.
Cytotoxicity
Cell culture
Cells lines including human monocytic THP-1, murine 
macrophage RAW 264.7 and the Vero monkey kidney 
cell lines were obtained from the American Type Culture 
Table 2 Acetylcholinesterase inhibitory activity of  three 
limonoids isolated from Trichilia welwitschii and reference 
compound (galantamine)
Values with different letters are significantly different at p < 0.05
Compounds Concentration  
(µg/mL)
% AChE inhibition IC50 (µg/mL)
1 50 94.33 ± 8.15 19.13 ± 0.41a
25 71.67 ± 6.03
12.5 18.00 ± 8.89
6.25 28.00 ± 6.56
2 50 82.67 ± 7.04 34.15 ± 1.66b
25 67.00 ± 4.36
12.5 47.33 ± 2.08
6.25 14.00 ± 6.00
3 50 87.00 ± 8.74 45.69 ± 3.65c
25 70.67 ± 3.50
12.5 31.67 ± 5.20
6.25 30.33 ± 3.51
Galantamine 20 83.00 ± 8.89 8.22 ± 2.73d
5 69.67 ± 4.16
2 57.67 ± 4.04






























Fig. 2 Compounds isolated from T. welwitschii. 1 Trichilia lactone D5; 2 rohituka 3; 3 dregeanin. The isolation procedure and the structure elucida-
tion of the compounds were previously described [9]
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Collection (Rockville, MD, USA). They were maintained 
in DMEM supplemented with 10 % fetal calf serum (FCS) 
and 1  % penicillin/streptomycin/fongizone (PSF) under 
standard cell culture conditions at 37 °C and 5 % CO2 in a 
humidified environment.
MTT assay
The cytotoxicity of compounds was determined by the 
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium 
(MTT) assay as previously described [23]. The selectivity 
index (SI) values were calculated by dividing cytotoxic-
ity LC50 values of normal Vero cells by the LC50 of cancer 
cells in the same units.
Nitric oxide inhibitory activity and viability 
of LPS-activated RAW 264.7 macrophages
The RAW 264.7 macrophages cells were seeded in 96 
well-microtitre plates and were activated by incubation 
in medium containing 1  µg/mL LPS alone (control) or 
lipopolysaccharide with different concentrations of the 
samples dissolved in DMSO. Quercetin served as a posi-
tive control NO inhibitor for the reduction of NO pro-
duction [18].
Measurement of nitrite
Nitric oxide released from macrophages was determined 
by measuring the nitrite concentration in culture super-
natant using the Griess reagent. After 24  h incubation, 
100 µL of supernatant from each well of cell culture plates 
was transferred into 96-well microtitre plates and an 
equal volume of Griess reagent was added. The absorb-
ance of the resultant solutions was determined on a 
BioTek Synergy microplate reader after 10 min at 550 nm. 
The concentrations of nitrite were derived from regres-
sion analysis using serial dilutions of sodium nitrite as a 
standard. Percentage inhibition was calculated based on 
the ability of compounds to inhibit nitric oxide formation 
by cells compared with the control (cells in media with-
out compounds), which was considered as 0 % inhibition.
Cell viability
To determine whether the observed nitric oxide inhibi-
tion was not due to cytotoxic effects, MTT assay was 
also performed on the macrophage cells as previously 
described [23].
Acetylcholinesterase inhibition activity
Inhibition of acetylcholinesterase activity was deter-
mined using Ellman’s colorimetric method [24] with 
slight modifications. In a 96-well plate was placed: 25 µL 
of 15 mmol/L ATCI in water, 125 µL of 3 mmol/L DTNB 
in Buffer A (50  mmol/L Tris–HCl, pH 8.0, containing 
0.1  mol/L NaCl and 0.02  mol/L MgCl2·6H2O), 50 µL 
of Buffer B (50  mmol/L, pH 8, containing 0.1  % bovine 
serum albumin) and 25 µL of samples (serially diluted: 
500–3.9 µg/mL for extract and fraction and 100–0.78 µg/
mL for compounds and galantamine used as AChE 
standard inhibitor). Then, AChE (0.2 U/mL) was added 
to the wells and the absorbance was determined spectro-
photometrically (BioTek Synergy microplate reader) at 
405 nm. Distilled water was used as negative control. The 
percentage of inhibition was calculated as follow: 
where V is the rate of the reaction in the presence of 
inhibitor and Vmax is the reaction’s rate of the control 
without inhibitor. The IC50 values of samples leading to 
50 % inhibition were calculated by plotting the percent-
age of inhibition against the concentrations.
Statistical analysis
All results are presented as means of triplicate experi-
ments. All experiments were conducted in triplicate and 
values expressed as mean  ±  standard deviation. Sta-
tistical analysis was performed with GraphPad InStat 
Software and results were compared using the Student-
Newman Keul test at 5, 1 or 0.1 % significance level.
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